Aspirin and Low-Molecular Weight Heparin Combination Therapy Effectively Prevents Recurrent Miscarriage in Hyperhomocysteinemic Women

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Chakraborty, Pratip ^a   Banerjee, Sayani ^b   Saha, Piyali ^b   Nandi, Shyam Sundar ^b   Sharma, Sunita ^a   Goswami, Sourendra K ^a   Chakravarty, Baidyanath ^a   Kabir, Syed N ^b  

^a Institute of Reproductive Medicine   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYANOCOBALAMIN; DALTEPARIN; FOLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; PROGESTERONE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERHOMOCYSTEINEMIA; INDIA; INSULIN RESISTANCE; MEDICAL HISTORY; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PREGNANCY; PROSPECTIVE STUDY; RECURRENT ABORTION; RECURRENT PREGNANCY LOSS;

ABORTION, HABITUAL; ADULT; ANTICOAGULANTS; ASPIRIN; DRUG THERAPY, COMBINATION; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERHOMOCYSTEINEMIA; INSULIN RESISTANCE; LIVE BIRTH; OBESITY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84883504712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074155     Document Type: Article

References (46)

1. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N, (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 21: 2216-2222.
2. Lee RM, Silver RM, (2000) Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med 18: 433-440.
3. Rai R, Backos M, Rushworth F, Regan L, (2000) Polycystic ovaries and recurrent miscarriage-a reappraisal. Hum Reprod 15: 612-615.
4. Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Alexandraki KI, (2007) Early onset adiposity: A pathway to polycystic ovary syndrome in adolescents? Hormones 6: 210-217.
5. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, et al. (2001) Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 45: 65-71.
6. Nelson SM, Greer IA, (2008) The potential role of heparin in assisted conception. Hum Reprod Update 14: 623-645.
7. D'Uva M, Di Micco P, Strina I, Ranieri A, Alviggi C, et al. (2008) Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy. Biologics 2: 897-902.
8. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, et al. (2003) Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 18: 721-727.
9. Wijeyaratne CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R, et al. (2004) Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol 60: 560-567.
10. Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ, (2007) Obesity and thrombosis. Eur J Vasc Endovasc Surg 33: 223-233.
11. Rai R, Cohen H, Dave M, Regan L, (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314: 253-257.
12. Farquharson RG, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized controlled trial of treatment. Obset Gynecol 100: 408-413. [Erratum, Obstet Gynecol (2002) 100: 1361].
13. Empson M, Lassere M, Craig J, Scott J, (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2: CD002859.
14. Rodger MA, Paidas M, McLintock C. Middeldorp S, Kahn S, et al. (2008) Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 112: 320-324.
15. Kwak-Kim J, Yang KM, Gilman-Sachs A, (2009) Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynecol Res 35: 609-622.
16. Matthiesen L, Kalkunte S, Sharma S, (2012) Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol 67: 334-340.
17. Shlebak A, Malik I, (2009) Managing heparin anticoagulation in patients with prosthetic cardiac valves: balancing the risk. Heart 95: 1643-1645.
18. Deruelle P, Denervaud M, Hachulla E, Ducloy-Bouthors A, Valat A, et al. (2006) Use of low-molecular-weight heparin from the first trimester of pregnancy: A retrospective study of 111 consecutive pregnancies. Eur J Obstet Gynecol Reprod Biol 127: 73-78.
19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47.
20. Chakraborty P, Ghosh S, Goswami SK, Kabir SN, Chakravarty BN, et al. (2013) Altered trace mineral milieu may play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biol Trace Elem Res 152: 9-15.
21. World Health Organization Technical Report Series 894 (2000) Obesity: preventing and managing the global epidemic, Geneva: World Health Organization.
22. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, et al. (2009) Low molecular weight heparin and aspirin for recurrent pregnancy loss: Results from the randomized, controlled HepASATrial. J Rheumatol 36: 279-287.
23. Dimitrakakis C, Papageorgiou P, Papageorgiou I, Antzaklis A, Sakarelou N, et al. (2000) Absence of transplacental passage of the low molecular weight heparin enoxaparin. Haemostasis 30: 243-248.
24. Greer IA, Nelson-Piercy C, (2005) Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systemic review of safety and efficacy. Blood 106: 40-405.
25. Baek KH, Lee EJ, Kim YS, (2007) Recurrent pregnancy loss: the key potential mechanisms. Trends Mol Med 13: 310-317.
26. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK, (2000) Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 74: 1196-1199.
27. Unfried G, Greismacher A, Weismuller W, Huber JC, Tempfer CB, (2002) The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gyn 99: 614-619.
28. Tian L, Shen H, Lu Q, Norman R J, Wang J, (2007) Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab 92: 1430-1433.
29. Lashen H, Fear K, Sturdee DW, (2004) Obesity is associated with increased risk of first trimester and recurrent miscarriage: Matched case-control study. Hum Reprod 19: 1644-1666.
30. Pritchand D (2006) An update in relation to common diseases: Report from Homocysteine Day. Available: http://www.homocysteineday.com/fileadmin/user_upload/homocysteineday/pdf/Homocysteine_report_2007.pdf. Accessed 2013 Mar 8.
31. Metwally M, Saravelos SH, Ledger WL, Li TC, (2010) Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 94: 290-295.
32. Ford HB, Schust D, (2009) Recurrent pregnancy loss: etiology, diagnosis and therapy. Rev Obstet Gynecol 2: 76-83.
33. Carp HJA, (2004) Antiphospholipid syndrome in pregnancy. Curr Opin Obstet Gynecol 16: 129-135.
34. Mak A, Cheung WLM, Cheak AA, Roger CH, (2010) Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. J Rheumatol 49: 281-288.
35. Lockshin MD, (1999) Pregnancy loss in the antiphospholipid syndrome. Thromb Haemost 82: 641-648.
36. Pacchiarotti A, Mohamed MA, Micara G, Linari A, Tranquilli D, et al. (2007) The possible role of hyperhomocysteinemia on IVF outcome. J Assist Reprod Genet 24: 459-462.
37. Tulpalla M, Viinikka L, Ylikorkaka O, (1991) Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet 387: 879-881.
38. Rushton DI (1988) Placental pathology in spontaneous miscarriage. In: Beard RW, Sharp F, editors. Early pregnancy loss. London: Springer: 149-157.
39. Brenner B, Bar J, Ellis M, Yarom I, Yohai D, et al. (2005) Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertil Steril 84: 770-773.
40. Kaandorp SP, Goddijn M, Post JAM, Hutten BA, Verhoeve HR, et al. (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 362: 1586-1596.
41. Kupferminc MJ, (2003) Thrombophilia and pregnancy. Reprod Biol Endocrinol 1: 111.
42. Check J, (2012) The use of heparin for preventing miscarriage. Am J Reprod Immunol 67: 326-333.
43. Craven CM, Ward K, (1999) Syncytiotrophoblastic fragments in first-trimester decidual veins: evidence of placental perfusion by the maternal circulation early in pregnancy. Am J Obstet Gynecol 181: 455-459.
44. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, et al. (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study. Ann Intern Med 143: 697-706.
45. Junqueira DR, Perini E, Penholati RR, Carvalho MG, (2012) Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 12: CD007557.
46. Chen Y, Wu XX, Tan JP, Liu ML, Liu YL, et al. (2012) Effects of low molecular weight heparin and heparin-binding epidermal growth factor on human trophoblast in first trimester. Fertil Steril 97: 764-770.